Edition:
United States

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

11.11USD
14 Dec 2018
Change (% chg)

$-0.09 (-0.80%)
Prev Close
$11.20
Open
$11.13
Day's High
$11.13
Day's Low
$10.62
Volume
254,978
Avg. Vol
216,626
52-wk High
$20.85
52-wk Low
$10.48

Chart for

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $863.35
Shares Outstanding(Mil.): 67.71
Dividend: --
Yield (%): --

Financials

  ALDR.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -5.14 -- --
ROI: -76.39 9.01 14.96
ROE: -76.45 10.15 16.52

Earnings vs. Estimates